Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 16293862

Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol INT-0102.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2005 Nov 20
First author
Hutchins LF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2006 May 20;24(15):2392; author reply 2392. doi: 10.1200/JCO.2006.05.7562.
    note
    Source null
    related pmid
    16710042
    relationship
    Comment in

Authors and identifiers

  1. name
    Hutchins LF
    type
    Author
  2. name
    Green SJ
    type
    Author
  3. name
    Ravdin PM
    type
    Author
  4. name
    Lew D
    type
    Author
  5. name
    Martino S
    type
    Author
  6. name
    Abeloff M
    type
    Author
  7. name
    Lyss AP
    type
    Author
  8. name
    Allred C
    type
    Author
  9. name
    Rivkin SE
    type
    Author
  10. name
    Osborne CK
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hutchins LF
    type
    Author
  2. name
    Green SJ
    type
    Author
  3. name
    Ravdin PM
    type
    Author
  4. name
    Lew D
    type
    Author
  5. name
    Martino S
    type
    Author
  6. name
    Abeloff M
    type
    Author
  7. name
    Lyss AP
    type
    Author
  8. name
    Allred C
    type
    Author
  9. name
    Rivkin SE
    type
    Author
  10. name
    Osborne CK
    type
    Author
bibliography ids
  1. nci-bib-67c49ca250770274610820cb
book metadata
content sha256
7cc7ab1cc1789881e0c080e7bdc3dda31ab09a915c2484ed7ef0a9076b9d2743
document type
citation
dois
  1. 10.1200/JCO.2005.08.071
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:16293862
immutable id
pubmed:16293862@7cc7ab1cc1789881e0c080e7bdc3dda31ab09a915c2484ed7ef0a9076b9d2743
journal
abbreviation
J Clin Oncol
issn electronic
Source null
issn print
0732-183X
issue
33
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
8313-21
volume
23
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2006 May 20;24(15):2392; author reply 2392. doi: 10.1200/JCO.2006.05.7562.
    note
    Source null
    related pmid
    16710042
    relationship
    Comment in
outcomes validated
false
pmid
16293862
provenance
batch id
a181c30258a88d182e78
provider
NCBI PubMed ESummary
record sha256
485ce283d5816987691342334928d65825f47dd1be84705b9af0da43607e0fcc
response sha256
558e0dce453ae424567844b062522ebd1d27363c3312c81dbf6f32a8ff08da24
retrieved at
2026-09-09T23:46:03.896343+00:00
publication date
display
2005 Nov 20
precision
day
year
2005
publication types
  1. Comparative Study
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/16293862/
title
Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol INT-0102.

Preserved source evidence · Not medical advice